Get Instant Summarized Text (Gist) CeSPIACE is a peptide inhibitor designed to block the interaction between the SARS-CoV-2 spike protein and ACE2 receptors, preventing infection. It remains ...

On the latest episode of his podcast, Tucker Carlson was left stunned after cancer researcher Dr Patrick Soon-Shiong revealed ...

Dr. Patrick Soon-Shiong said of rising cancer rates and COVID "it's not a coincidence" regarding both the virus and the shots.

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors. Blocking this interaction with inhibitors could prevent ...

CoV-2, a new merbecovirus found in bats across China, that utilises the ACE2 receptor for cellular entry—raising concerns ...

Last week, a blogger wrote about a Yale School of Medicine study that he alleged proved that millions of long covid sufferers might, in fact have been injured by the vaccine. The story blew up on ...

The spike protein of the coronavirus, or SARS-CoV-2, binds to ACE2, a receptor on the host cells, which allows the virus to enter the cells and infect it. Binding is the first step for infection, and ...

1, KP.3.1.1, XEC and LP.8.1. PEMGARDA targets the SARS-CoV-2 spike protein receptor binding domain (RBD), thereby inhibiting virus attachment to the human ACE2 receptor on host cells. PEMGARDA ...